Soergel K H, Whalen G E, Harris J A, Geenen J E
J Clin Invest. 1968 May;47(5):1071-82. doi: 10.1172/JCI105797.
The effect of i.v. Pitressin (ADH) in a dose of 1 U/hr on permeability characteristics and on absorptive capacity of the normal human small intestine was investigated. The method of continuous intestinal perfusion was employed with polyethylene glycol 4000 as a nonabsorbable marker. Unidirectional flux rates of Na and H(2)O were calculated from the disappearance of (22)Na and of (3)HOH from isotonic saline solution within the intestinal lumen. Each study consisted of two successive perfusion periods: one while the subject was hydrated, the other during ADH infusion or while the subject was dehydrated. Water and sodium absorption from isotonic NaCl occurred in the hydrated state and was abolished by ADH as well as by dehydration in the jejunum. In some instances, net gain of water and sodium in the lumen occurred. In the ileum, ADH and dehydration caused a decrease in water and sodium absorption rate. By contrast, unidirectional flux into the intestinal lumen of water and sodium, as well as dextrose and D-xylose diffusion, remained unchanged by ADH. During perfusions with hypertonic urea solutions the rates of sodium and water entry into the intestine were greatly increased during i.v. ADH infusion, whereas urea loss from the study segment remained constant. ADH in the dosage used did not affect human intestinal motility. The results suggest that circulating ADH in physiologic concentrations affects the small intestine in one of two ways: increased secretion of water and salt into the lumen or direct interference with the active sodium transport mechanism.
研究了以每小时1单位的剂量静脉注射垂体后叶素(抗利尿激素)对正常人体小肠通透性特征和吸收能力的影响。采用连续肠道灌注法,以聚乙二醇4000作为非吸收性标记物。根据肠腔内等渗盐溶液中²²Na和³HOH的消失情况计算Na和H₂O的单向通量率。每项研究包括两个连续的灌注期:一个是受试者处于水合状态时,另一个是在抗利尿激素输注期间或受试者处于脱水状态时。等渗NaCl中的水和钠吸收在水合状态下发生,在空肠中抗利尿激素以及脱水均可使其消除。在某些情况下,肠腔内会出现水和钠的净增加。在回肠中,抗利尿激素和脱水导致水和钠的吸收速率降低。相比之下,抗利尿激素并未改变水和钠进入肠腔的单向通量以及葡萄糖和D-木糖的扩散。在用高渗尿素溶液灌注期间,静脉注射抗利尿激素时钠和水进入肠道的速率大幅增加,而研究段的尿素损失保持不变。所用剂量的抗利尿激素不影响人体肠道运动。结果表明,生理浓度的循环抗利尿激素以两种方式之一影响小肠:增加水和盐向肠腔的分泌或直接干扰主动钠转运机制。